About

 Macro Scope BioConsulting is a dynamic consultancy firm that utilizes the principles of microbial ecology to provide comprehensive solutions in microbiology. 

Our core focus is on bioburden, sterility testing, and environmental monitoring, where we utilize both traditional and innovative rapid microbiological methods that meet the standards required by regulatory agencies. 

We offer a holistic perspective that guides clients in selecting the most appropriate microbiological methods and we provide comprehensive assistance in implementation and method optimization.

Our expertise extends to diverse sectors, including the pharmaceutical industry, encompassing cell & gene therapy and bioproduction. Additionally, we cater to the home and personal care, as well as the dairy, food, and beverage industries. By understanding the unique microbiological challenges inherent in each industry, we tailor our solutions to address specific needs effectively.

At Macro Scope BioConsulting, our commitment lies in delivering holistic microbiological services that not only meet regulatory requirements but also prioritize the safety of patients and consumers. Through our collaborative approach, we empower clients to navigate complex microbiological landscapes with confidence and assurance.

Lori has over 30 years’ of experience in clinical, environmental, and industrial microbiology.  She is a technical expert on rapid and alternative microbiological methods and is an active member of the Parenteral Drug Association (PDA), the Association for the Advancement of Blood & Biotherapies (AABB), the International Society of Blood Transfusion (ISBT), and the International Society for Cell & Gene Therapy (ISCT).

Lori previously worked at bioMérieux as their Sr Director of Scientific Affairs providing support to the Pharma Quality Control business. While at bioMérieux, Lori identified and implemented improved detection of mold and Cutibacterium acnes for the  BACT/ALERT® 3D Microbial Detection System. She excelled at engaging with customers, understanding their needs, and assisting with technical issues. She authored numerous technical whitepapers, presented at several conferences as well as recorded webinars on microbiological solutions for the biopharmaceutical industry. She has presented to both the FDA’s Center for Biological Evaluation and Research (CBER) and the Center for Drug Evaluation and Research (CDER) as part of the FDA’s Emerging Technology Program and Compounding Quality Center of Excellence, respectively.

Before joining bioMérieux, Lori worked for 11 years at Celsis, a leading rapid microbiological method supplier utilizing ATP bioluminescence, in a variety of technical roles including VP of Scientific Affairs and Reagent Development. While at Celsis, she created and implemented a global technical management program with standardized SOPs, training material, account management, application laboratory support, and customer technical reports. She was the key technical resource for R&D, product management, and marketing and helped analyze and lead their next-generation rapid method using a concentrating pipettor and hollow-fiber tips with Celsis AMPiScreen reagent technology.

Lori received her PhD from the University of Minnesota in Microbial Ecology studying the influence of earthworm activity on microbial gene transfer in the environment. She performed postdoctoral research at Rutgers University focusing on phytoremediation of polyaromatic hydrocarbons and the use of earthworm egg capsules as a mechanism to disperse beneficial microorganisms, and at the Los Alamos National Laboratory using molecular tools to study microbial communities associated with cryptobiotic soil crusts. She also holds a Master’s degree in Limnology and a Bachelor’s degree in Medical Technology.